Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Cytisinicline

Summary

Persistence. It cannot be excluded that cytisinicline is persistent, due to the lack of data.

Bioaccumulation. It cannot be excluded that cytisinicline bioaccumulates, due to the lack of data.

Toxicity. It cannot be excluded that cytisinicline is toxic, due to the lack of data.

Risk. Risk of environmental impact of cytisinicline cannot be excluded, due to the lack of environmental toxicity data.

 

Environmental information is missing on fass.se for cytisinicline (2024-09-11).

Detailed information

Assessment report

Assessment report for Cerdablan (cytisinicline) Asp no: 2021-0351, Swedish Medical Products Agency.

"Environmental Risk Assessment (ERA)
Since product name is a generic product, it will not lead to an increased exposure to the environment. An environmental risk assessment is therefore not deemed necessary."

Author: Health and Medical Care Administration, Region Stockholm